Intraneuronal Aβ accumulation, amyloid plaques, and synapse pathology in Alzheimer's disease

Neurodegenerative Diseases

Volumn 10, Issue 1-4, 2012, Pages 56-59

  Capetillo Zarate, Estibaliz ^a   Gracia, Luis ^a   Tampellini, Davide ^b   Gouras, Gunnar K ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Alzheimer's disease; Amyloid; Neuropathology; Synapse

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; STRUCTURAL PROTEIN;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; MOUSE; NEURITE; NEUROIMAGING; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; SYNAPSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BACTERIAL PROTEINS; DISEASE MODELS, ANIMAL; HUMANS; LUMINESCENT PROTEINS; MICE; MICE, TRANSGENIC; NEUROFIBRILLARY TANGLES; NEURONS; PLAQUE, AMYLOID; SYNAPSES;

EID: 84860216294     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000334762     Document Type: Article

References (35)

1. Gouras GK, Tsai J, Naslund J, Vincent B, Edgar M, Checler F, Greenfield JP, Haroutunian V, Buxbaum JD, Xu H, Greengard P, Relkin NR: Intraneuronal A3β 42 42 accumulation in human brain. Am J Pathol 2000; 156: 15-20.
2. D'Andrea MR, Nagele RG, Wang HY, Peterson PA, Lee DH: Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease. Histopathology 2001; 38: 120-134.
3. Gyure KA, Durham R, Stewart WF, Smialek JE, Troncoso JC: Intraneuronal A3β 42-amyloid precedes development of amyloid plaques in Down syndrome. Arch Pathol Lab Med 2001; 125: 489-492.
4. Wirths O, Multhaup G, Czech C, Blanchard V, Moussaoui S, Tremp G, Pradier L, Beyreuther K, Bayer TA: Intraneuronal A3β accumulation precedes plaque formation in3β 42-amyloid precursor protein and presenilin- 1 double-transgenic mice. Neurosci Lett 2001; 306: 116-120.
5. Takahashi RH, Milner TA, Li F, Nam EE, Edgar MA, Yamaguchi H, Beal MF, Xu H, Greengard P, Gouras GK: Intraneuronal Alz heimer A3β 42 42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am J Pathol 2002; 161: 1869-1879.
6. Busciglio J, Pelsman A, Wong C, Pigino G, Yuan M, Mori H, Yankner BA: Altered metabolism of the amyloid3β precursor protein is associated with mitochondrial dysfunction in Down's syndrome. Neuron 2002; 33: 677-688.
7. Mori C, Spooner ET, Wisniewsk KE, Wisniewski TM, Yamaguch H, Saido TC, Tolan DR, Selkoe DJ, Lemere CA: Intraneuronal A3β 42 42 accumulation in Down syndrome brain. Amyloid 2002; 9: 88-102.
8. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM: Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular A3β and synaptic dysfunction. Neuron 2003; 39: 409-421.
9. Lord A, Kalimo H, Eckman C, Zhang XQ, Lannfelt L, Nilsson LN: The Arctic Alzheimer mutation facilitates early intraneuronal A3β aggregation and senile plaque formation in transgenic mice. Neurobiol Aging 2006; 27: 67-77.
10. Knobloch M, Konietzko U, Krebs DC, Nitsch RM: Intracellular A3β and cognitive deficits precede3β 42-amyloid deposition in transgenic arcA3β mice. Neurobiol Aging 2007; 28: 1297-1306.
11. Van Broeck B, Vanhoutte G, Pirici D, Van Dam D, Wils H, Cuijt I, Vennekens K, Zabielski M, Michalik A, Theuns J, De Deyn PP, Van der Linden A, Van Broeckhoven C, Kumar- Singh S: Intraneuronal amyloid3β and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease. Neurobiol Aging 2008; 29: 241-252.
12. Philipson O, Lannfelt L, Nilsson LN: Genetic and pharmacological evidence of intraneuronal A3β accumulation in APP transgenic mice. FEBS Lett 2009; 583: 3021-3026.
13. Espana J, Gimenez-Llort L, Valero J, Minano A, Rabano A, Rodriguez-Alvarez J, LaFerla FM, Saura CA: Intraneuronal3β- amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer's disease transgenic mice. Biol Psychiatry 2010; 67: 513-521.
14. Leon WC, Canneva F, Partridge V, Allard S, Ferretti MT, Dewilde A, Vercauteren F, Atifeh R, Ducatenzeiler A, Klein W, Szyf M, Alhonen L, Cuello AC: A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-3β -associated cognitive impairment. J Alzheimers Dis 2010; 20: 113-126.
15. Nunomura A, Tamaoki T, Tanaka K, Motohashi N, Nakamura M, Hayashi T, Yamaguchi H, Shimohama S, Lee HG, Zhu X, Smith MA, Perry G: Intraneuronal amyloid3β accumulation and oxidative damage to nucleic acids in Alzheimer disease. Neurobiol Dis 2010; 37: 731-737.
16. Yang AJ, Knauer M, Burdick DA, Glabe C: Intracellular A3β 1-42 aggregates stimulate the accumulation of stable, insoluble amyloidogenic fragments of the amyloid precursor protein in transfected cells. J Biol Chem 1995; 270: 14786-14792.
17. Takahashi RH, Almeida CG, Kearney PF, Yu F, Lin MT, Milner TA, Gouras GK: Oligomerization of Alzheimer's3β 42-amyloid within processes and synapses of cultured neurons and brain. J Neurosci 2004; 24: 3592-3599.
18. Casas C, Sergeant N, Itier JM, Blanchard V, Wirths O, van der Kolk N, Vingtdeux V, van de Steeg E, Ret G, Canton T, Drobecq H, Clark A, Bonici B, Delacourte A, Benavides J, Schmitz C, Tremp G, Bayer TA, Benoit P, Pradier L: Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated A3β 42 42 accumulation in a novel Alzheimer transgenic model. Am J Pathol 2004; 165: 1289-1300.
19. Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, Guillozet-Bongaarts A, Ohno M, Disterhoft J, Van Eldik L, Berry R, Vassar R: Intraneuronal3β 42-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J Neurosci 2006; 26: 10129-10140.
20. Davies CA, Mann DM, Sumpter PQ, Yates PO: A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease. J Neurol Sci 1987; 78: 151-164.
21. DeKosky ST, Scheff SW: Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann Neurol 1990; 27: 457-464.
22. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R: Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 1991; 30: 572-580.
23. Sze CI, Troncoso JC, Kawas C, Mouton P, Price DL, Martin LJ: Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease. J Neuropathol Exp Neurol 1997; 56: 933-944.
24. Selkoe DJ: Alzheimer's disease is a synaptic failure. Science 2002; 298: 789-791.
25. Lue LF, Kuo YM, Roher AE, Brachova L, Shen Y, Sue L, Beach T, Kurth JH, Rydel RE, Rogers J: Soluble amyloid3β peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol 1999; 155: 853-862.
26. McLean CA, Cherny RA, Fraser FW, Fuller SJ, Smith MJ, Beyreuther K, Bush AI, Masters CL: Soluble pool of A3β amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol 1999; 46: 860-866.
27. Tampellini D, Capetillo-Zarate E, Dumont M, Huang Z, Yu F, Lin MT, Gouras GK: Effects of synaptic modulation on3β 42-amyloid, synaptophysin, and memory performance in Alzheimer's disease transgenic mice. J Neurosci 2010; 30: 14299-14304.
28. Almeida CG, Takahashi RH, Gouras GK:3β- amyloid accumulation impairs multivesicular body sorting by inhibiting the ubiquitinproteasome system. J Neurosci 2006; 26: 4277-4288.
29. Capetillo-Zarate E, Gracia L, Yu F, Banfelder JR, Lin MT, Tampellini D, Gouras GK: Highresolution 3D reconstruction reveals intrasynaptic amyloid fibrils. Am J Pathol 2011; 179: 2551-2558.
30. Gouras GK, Tampellini D, Takahashi RH, Capetillo-Zarate E: Intraneuronal3β 42-amyloid accumulation and synapse pathology in Alzheimer's disease. Acta Neuropathol 2010; 119: 523-541.
31. Aho L, Pikkarainen M, Hiltunen M, Leinonen V, Alafuzoff I: Immunohistochemical visualization of amyloid-3β protein precursor and amyloid-3β in extra- and intracellular compartments in the human brain. J Alzheimers Dis 2010; 20: 1015-1028.
32. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG: Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 2003; 300: 486-489.
33. Langer F, Eisele YS, Fritschi SK, Staufenbiel M, Walker LC, Jucker M: Soluble A3β seeds are potent inducers of cerebral3β 42-amyloid deposition. J Neurosci 2011; 31: 14488-14495.
34. Tampellini D, Rahman N, Gallo EF, Huang Z, Dumont M, Capetillo-Zarate E, Ma T, Zheng R, Lu B, Nanus DM, Lin MT, Gouras GK: Synaptic activity reduces intraneuronal A3β , promotes APP transport to synapses, and protects against A3β -related synaptic alterations. J Neurosci 2009; 29: 9704-9713.
35. Yang AJ, Chandswangbhuvana D, Shu T, Henschen A, Glabe CG: Intracellular accumulation of insoluble, newly synthesized A3β N-42 in amyloid precursor protein-transfected cells that have been treated with A3β 1- 42. J Biol Chem 1999; 274: 20650-20656.